Vasoplegic syndrome: A challenge to anaesthetic management

Abstract

Perioperative hypotension is a well-recognized and relatively common problem during surgery. Vasoplegic syndrome is one such condition which is characterized by severe persistent hypotension with normal to high cardiac output and low systemic resistance. It is commonly seen in patients undergoing cardiac surgery on cardiopulmonary bypass. However, this syndrome has also been reported in off pump surgeries. Management of intraoperative hypotension may be challenging for an anaesthesiologist, if it does not respond or poorly respond to conventional therapy. We report the management of a hypertensive patient posted for spine surgery in prone position, who developed severe hypotension under anaesthesia refractory to treatment.

Keywords

Anaesthesia - angiotensin converting enzyme inhibitor - refractory hypotension - vasoplegic syndrome

• REFERENCES

• 1 Shanmugam G. Vasoplegic syndrome-the role of methylene blue. Eur J Cardiothorac Surg 2005; 28: 705-10
• 2 Gomes WJ, Carvalho AC, Palma JH, Goncalves Jr I, Buffolo E. Vasoplegic syndrome: A new dilemma. J Thorac Cardiovasc Surg 1994; 107: 942-3
• 3 Lange M, Van Aken H, Westphal M Morelli A. Role of vasopressinergic V1 receptor agonists in the treatment of perioperative catecholamine-refractory arterial hypotension. Best Pract Res Clin Anaesthesiol 2008; 22: 369-81
• 4 Mekonsto-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patient with preserved left ventricular function. Ann Thorac Surg 2001; 71: 1428-32
• 5 Meadows D, Edwards JD, Wilkins RG, Nightingale P. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16: 663-6
• 6 Kwok ES, Howes D. Use of methylene blue in sepsis. A systematic review. J Intensive Care Med 2006; 21: 359-63
• 7 Smith I, Jackson I. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: Should they be stopped or not before ambulatory anaesthesia?. Curr Opin Anesthesiol 2010; 23: 687-90
• 8 Turan A, You J, Shiba A, Kurz A, Saager L, Sessler DI. Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth Analg 2012; 114: 552-60
• 9 Wolf A, McGoldrick KE. Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia. Cardiol Rev 2011; 19: 12-6
• 10 Powers FM, Pifarre R, Thomas Jr. JX. Ventricular dysfunction in norepinephrine-induced cardiomyopathy. Circ Shock 1994; 43: 122-9
• 11 Morales D, Madigan J, Cullinane S, Chen J, Heath M, Oz M. et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999; 100: 226-9
• 12 Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF. et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81: 299-307
• 13 Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: A systematic review of the literature. Crit Care Med 2009; 37: 2642-7
• 14 Oliveira Neto AM, Duarte NM, Vicente WV, Viaro F, Evora PR. Methylene blue: An effective treatment for contrast medium-induced anaphylaxis. Med Sci Monit 2003; 9: CS102-6
• 15 Fischer GW, Levin MA. Vasoplegia during cardiac surgery: Current concepts and management. Semin Thorac Cardiovasc Surg 2010; 22: 140-4
• 16 Weiner MM, Lin HM, Danforth D, Rao S, Hosseinian L, Fischer GW. Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth 2013; 27: 1233-8